Treatment Study Group of Chronic Renal Disease of Italian Society of Nephrology, Italy Official Nephrologist Consultant of Regional Health Institution of Sardinia, Cagliari, Italy,
Department of Public Health, Clinical and Molecular Medicine-University of Cagliari, Cagliari, Italy.
Blood Purif. 2021;50(2):246-253. doi: 10.1159/000509790. Epub 2020 Oct 20.
The initial once-weekly administration of incremental hemodialysis to patients with residual kidney function (RKF) has recently attracted considerable interest.
The aim of our study was to assess the performance of a series of different methods in measuring serum urea nitrogen and serum Cr (sCr) RKF in patients on once-weekly hemodialysis (1WHD). Evaluations were carried out by means of 24-h predialysis urine collection (Kr-24H) or 6-day inter-dialysis collection (Kr-IDI) and estimation of glomerular filtration rate based on (KrSUN + KrsCr)/2 for the purpose of identifying a simple reference calculation to be used in assessing RKF in patients on 1WHD dialysis. Ninety-five urine samples were collected from 12 1WHD patients. A solute solver urea and Cr kinetic modeling program was used to calculate residual urea and Cr clearances. Mann-Whitney U test, Pearson's correlation coefficient (R), and linear determination coefficient (R2) were used for statistical analysis.
1WHD patients displayed a mean KrSUN-IDI of 4.5 ± 1.2 mL/min, while KrSUN-24H corresponded to 4.1 ± 0.9 mL/min, mean KrsCr-IDI to 9.1 ± 4.0 mL/min, and KrsCr 24H to 8.9 ± 4.2 mL/min, with a high regression between IDI and 24-h clearances (for IDI had R2 = 0.9149 and for 24H had R2 = 0.9595). A good correlation was also observed between KrSUN-24H and (KrSUN + KrsCR/2) (R2 = 0.7466, p < 0.01.
Urine collection over a 24-h predialysis period yielded similar results for both KrSUN and KrsCr compared to collection over a longer interdialytic interval (KrSUN + KrsCr)/2 could be applied to reliably assess RKF in patients on 1WHD.
The parameters evaluated are suitable for use as a routine daily method indicating the commencement and continued use of the 1WHD Incremental Program.
最近,人们对具有残余肾功能(RKF)的患者进行每周一次递增血液透析的初始治疗方案产生了浓厚的兴趣。
我们的研究目的是评估一系列不同方法在测量每周一次血液透析(1WHD)患者血清尿素氮和血清肌酐(sCr)RKF 中的表现。通过 24 小时预透析尿液收集(Kr-24H)或 6 天的透析间隔收集(Kr-IDI)来进行评估,并基于(KrSUN + KrsCr)/2 估算肾小球滤过率,目的是确定一种简单的参考计算方法,用于评估 1WHD 透析患者的 RKF。从 12 名 1WHD 患者中收集了 95 个尿液样本。使用溶质求解器尿素和 Cr 动力学建模程序来计算残余尿素和 Cr 清除率。使用 Mann-Whitney U 检验、Pearson 相关系数(R)和线性确定系数(R2)进行统计分析。
1WHD 患者的平均 KrSUN-IDI 为 4.5±1.2mL/min,而 KrSUN-24H 为 4.1±0.9mL/min,平均 KrsCr-IDI 为 9.1±4.0mL/min,KrsCr 24H 为 8.9±4.2mL/min,ID 与 24 小时清除率之间具有高度回归(ID 的 R2=0.9149,24 小时的 R2=0.9595)。KrSUN-24H 与(KrSUN + KrsCR/2)之间也存在良好的相关性(R2=0.7466,p<0.01)。
与更长的透析间隔期相比(KrSUN + KrsCr)/2,24 小时预透析期间的尿液收集在 KrSUN 和 KrsCr 方面都得到了相似的结果,可以可靠地评估 1WHD 患者的 RKF。
所评估的参数适合作为常规日常方法使用,表明开始和继续使用 1WHD 递增方案。